Amgen has maintained an impressive dividend streak over the past decade. The company's business should allow it to maintain this momentum for a while....
24/7 Wall St. Insights Jefferies is one of Wall Street's fastest-growing firms....
Amgen has been one of the best performing stocks since its IPO in 1983. Over the prior 12 months, the biotech's shares have continued this rich tradition....
Novo Nordisk (NVO) and Eli Lilly (LLY) both made headlines recently with positive drug trial results for their respective GLP-1 weight-loss drugs, as well as their approval in China. While these names...
Amgen (AMGN) closed at $319.31 in the latest trading session, marking a +0.36% move from the prior day....
The drugmaker has a promising weight-loss drug in clinical trials, MariTide, which could be a game changer. Recent acquisitions have bolstered Amgen's portfolio, which could pave the way for even more...
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects....
Biotech stocks operate under a core ethos. While there's been much talk about financially viable sectors – from tech to cryptocurrencies to even precious metals – when you think about it, nothing ...
Amgen continues to delight investors with the growth in sales of its key blockbusters and the expansion of its portfolio of medications. In mid-June, Amgen pleased investors by announcing that the FDA...
Amgen's (AMGN) Blincyto is now approved for the treatment of adult and pediatric patients one month and older with Philadelphia chromosome-negative B-ALL in the consolidation phase, regardless of MRD ...
Dow Jones stocks to watch in the stock market this week....